Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for Depression in Advanced Cancer
NCT00387348Phase 3Terminated
- Sponsor
- Massachusetts General Hospital
- Start
- Mar 2006
- Primary completion
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of escitalopram in major depressive disorder (MDD), sponsored by Massachusetts General Hospital. Started Mar 2006; status: terminated.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00387348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00387348.